Healthy Inc > Blog > Rheumatoid Arthritis medication export
Posted on:

What is Sulfasalazine 500mg used for?

In the pharmaceutical industry, Sulfasalazine 500mg is a specialized Disease-Modifying Anti-Rheumatic Drug (DMARD) and a prodrug of 5-aminosalicylic acid.As a pharmacist and manufacturer, I view Sulfasalazine as a “dual-action” agent. It is unique because it combines an antibacterial component with an anti-inflammatory component to treat chronic inflammatory conditions in both the joints and the gut.

Primary Clinical Uses

  • Ulcerative Colitis: It is a first-line therapy for inducing and maintaining remission in patients with mild-to-moderate ulcerative colitis.

  • Crohn’s Disease: Used to manage active Crohn’s disease, particularly when it affects the colon.

  • Rheumatoid Arthritis (RA): Prescribed for patients who have not responded sufficiently to salicylates or other NSAIDs. It is often part of the “triple therapy” regimen for RA.

  • Ankylosing Spondylitis: Used to reduce inflammation in the spine and joints.

Mechanism of Action: The Prodrug Split

Sulfasalazine is not active in its original form. It requires the “work” of gut bacteria to become effective.

Bacterial Cleavage: When the 500mg tablet reaches the colon, bacterial enzymes (azoreductases) break it down into two parts: Sulfapyridine and 5-Aminosalicylic acid (5-ASA/Mesalamine).

Gut Action (5-ASA): The 5-ASA stays mostly in the colon, where it acts locally to reduce inflammation by inhibiting prostaglandin and leukotriene synthesis. This is the primary mechanism for treating Colitis.

Systemic Action (Sulfapyridine): The Sulfapyridine is absorbed into the bloodstream. While it was originally an antibiotic, in this context, it is believed to be the component responsible for the systemic immunomodulatory effects that help with Rheumatoid Arthritis.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Sulfasalazine 500mg requires specific technical considerations:

  • Enteric Coating (EC) vs. Plain: Most international B2B buyers prefer the Enteric Coated (Delayed Release) version. This prevents the tablet from dissolving in the stomach, significantly reducing the common side effect of gastric upset (nausea/vomiting). Marketing this as a “Gentle-on-the-Stomach” formulation is a major USP for your digital platform.

  • The “Yellow-Orange” Discoloration: As a pharmacist, you should include in your technical literature that Sulfasalazine can turn urine or skin yellow-orange. This is harmless but critical for patient education and building trust with your distributors.

  • Stability: Sulfasalazine is light-sensitive. At our facility, we utilize Alu-Alu or high-grade PVC/PVDC blisters to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • Dossier Support: This is an “Essential Medicine.” We provide full CTD/eCTD Dossiers with rigorous dissolution profiles to help you register and export this to global pharmacy chains and government health departments.

Sulfasalazine Tablet

Posted on:

What is Sulfasalazine 500mg used for?

In the pharmaceutical industry, Sulfasalazine 500 mg is a potent Disease-Modifying Anti-Rheumatic Drug (DMARD) and an aminosalicylate. As a pharmacist and manufacturer, I classify this as a “dual-action” prodrug because it consists of two parts: a salicylate (for inflammation) and a sulfonamide antibiotic (which, in this case, acts as a carrier).

Primary Clinical Uses

  • Ulcerative Colitis: Used to treat active episodes and as maintenance therapy to keep the disease in remission.

  • Crohn’s Disease: Particularly effective when the disease involves the colon.

  • Rheumatoid Arthritis (RA): Indicated for patients who have not responded sufficiently to salicylates or other standard NSAIDs.

  • Ankylosing Spondylitis: Used to manage inflammation in the spine and joints.

Mechanism of Action: The Colonic Split

Sulfasalazine is unique because it is not absorbed well in the stomach; it is designed to travel to the lower intestine before it starts working.

The Prodrug Link: The molecule consists of 5-Aminosalicylic acid (5-ASA) linked to Sulfapyridine by a chemical bond.

Bacterial Cleavage: When the tablet reaches the colon, bacterial enzymes (azoreductases) break this bond, releasing the two components.

Local Anti-inflammatory (5-ASA): The 5-ASA stays in the colon to reduce inflammation directly at the site of the disease. It inhibits prostaglandin and leukotriene synthesis.

Systemic Action (Sulfapyridine): The Sulfapyridine is absorbed into the bloodstream. While it was originally an antibiotic, in this formulation, it is believed to provide the “DMARD” effect seen in Rheumatoid Arthritis.

The Manufacturer’s Perspective: Formulation & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Sulfasalazine 500 mg requires specific technical handling:

  • Delayed-Release (Enteric Coated): As a firm owner, you should prioritize Enteric-Coated (EC) tablets. This prevents the drug from dissolving in the stomach, which significantly reduces the common side effect of gastric upset. This is a major USP for your digital platform.

  • Photosensitivity: Sulfasalazine is sensitive to light. At our facility, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, preventing the orange-yellow API from degrading during export to Zone IVb regions.

  • Technical Sales Note: As a pharmacist, you know Sulfasalazine can interfere with Folic Acid absorption. Including a recommendation for folic acid supplementation in your Product Information Leaflet (PIL) demonstrates high-level clinical expertise to international B2B buyers.

  • Dossier Support: This is a specialized chronic care medication. We provide full CTD/eCTD Dossiers to support your firm in registering this as a reliable generic against the innovator (Azulfidine).

Sulfasalazine Tablet

 

Add to cart